Shanghai Labway Clinical Laboratory Co Ltd (301060) - Total Liabilities
Based on the latest financial reports, Shanghai Labway Clinical Laboratory Co Ltd (301060) has total liabilities worth CN¥760.43 Million CNY (≈ $111.27 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Shanghai Labway Clinical Laboratory Co L to assess how effectively this company generates cash.
Shanghai Labway Clinical Laboratory Co Ltd - Total Liabilities Trend (2013–2024)
This chart illustrates how Shanghai Labway Clinical Laboratory Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 301060 financial resilience to evaluate the company's liquid asset resilience ratio.
Shanghai Labway Clinical Laboratory Co Ltd Competitors by Total Liabilities
The table below lists competitors of Shanghai Labway Clinical Laboratory Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ZJBC Information Technology Co Ltd
SHE:000889
|
China | CN¥818.07 Million |
|
Contrel Technology Co Ltd
TWO:8064
|
Taiwan | NT$2.14 Billion |
|
Wecome Pharmaceutical Co Ltd
SHE:300878
|
China | CN¥458.37 Million |
|
iQIYI Inc
F:IQ8
|
Germany | €32.45 Billion |
|
Poly Union Chemical Holding Group Co Ltd
SHE:002037
|
China | CN¥14.05 Billion |
|
Tipco Asphalt Public Company Limited
F:NVP5
|
Germany | €8.25 Billion |
|
Jiangxi Huawu Brake Co Ltd
SHE:300095
|
China | CN¥1.50 Billion |
|
PWR Holdings Ltd
AU:PWH
|
Australia | AU$88.11 Million |
Liability Composition Analysis (2013–2024)
This chart breaks down Shanghai Labway Clinical Laboratory Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Shanghai Labway Clinical Laboratory Co L stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.08 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.48 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.31 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shanghai Labway Clinical Laboratory Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shanghai Labway Clinical Laboratory Co Ltd (2013–2024)
The table below shows the annual total liabilities of Shanghai Labway Clinical Laboratory Co Ltd from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥803.00 Million ≈ $117.50 Million |
-20.23% |
| 2023-12-31 | CN¥1.01 Billion ≈ $147.31 Million |
-31.71% |
| 2022-12-31 | CN¥1.47 Billion ≈ $215.71 Million |
+216.56% |
| 2021-12-31 | CN¥465.67 Million ≈ $68.14 Million |
+107.77% |
| 2020-12-31 | CN¥224.13 Million ≈ $32.80 Million |
+20.57% |
| 2019-12-31 | CN¥185.89 Million ≈ $27.20 Million |
-29.09% |
| 2018-12-31 | CN¥262.15 Million ≈ $38.36 Million |
+16.17% |
| 2017-12-31 | CN¥225.66 Million ≈ $33.02 Million |
-31.46% |
| 2016-12-31 | CN¥329.25 Million ≈ $48.18 Million |
+26.39% |
| 2015-12-31 | CN¥260.50 Million ≈ $38.12 Million |
-0.62% |
| 2014-12-31 | CN¥262.14 Million ≈ $38.36 Million |
+32.03% |
| 2013-12-31 | CN¥198.54 Million ≈ $29.05 Million |
-- |
About Shanghai Labway Clinical Laboratory Co Ltd
Shanghai Labway Clinical Laboratory Co., Ltd. engages in the sale of in-vitro diagnostic products in China. The company distributes in-vitro diagnostic instruments, reagents, and related accessories and consumables. It also provides third-party medical testing, pathological diagnosis services, precision medicine, CRO, and sample bank laboratory services; scientific research technology and testing… Read more